Valuation: GC Genome Corporation

Market Cap 13TCr 9.12Cr 7.9Cr 7.38Cr 6.75Cr 13Cr 870.2Cr 13Cr 87Cr 34Cr 435.34Cr 34Cr 34Cr 1.45TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 7Cr 49.35T 42.72T 39.93T 36.49T 68.77T 47.06L 69.85T 5L 2L 23.55L 2L 2L 78.42L EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.24x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day+4.59%
1 week+18.91%
Current month+18.91%
1 month+20.88%
3 months-26.38%
6 months-38.47%
Current year-19.79%
1 week 4,865
Extreme 4865
5,470
1 month 4,100
Extreme 4100
5,470
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap.
17/06/25 Free

Chief Executive Officer

1,69,285 -
17/06/25 Free 1,38,250 -
Change 5-day change 1-year change 3-year change Capi.($)
+4.59%+18.91%-32.22% - 8.78Cr
-1.16%+18.89%+109.51%+509.28% 4.64TCr
+0.67%+3.92%+20.86%+48.60% 2.59TCr
+0.67%+2.47%-19.02%-34.52% 776.42Cr
+6.76%+21.17%+44.83%+145.26% 569.19Cr
+1.16%+2.56%+22.50%+63.98% 339.07Cr
+1.04%+19.61%-25.92%+1,240.45% 229.87Cr
+0.36%+8.76%+186.72%+12.21% 212.88Cr
+6.83%+11.49%+2.48%-53.01% 198.86Cr
+4.04%+15.84%+33.80%-8.80% 184Cr
Average +2.37%+8.13%+34.35%+213.72% 975.04Cr
Weighted average by Cap. +0.25%+9.95%+63.69%+291.89%

Financials

2026 *2027 *
Net sales 3.9TCr 2.75Cr 2.38Cr 2.23Cr 2.03Cr 3.83Cr 262.33Cr 3.89Cr 26Cr 10Cr 131.24Cr 10Cr 10Cr 437.1Cr 4.88TCr 3.44Cr 2.98Cr 2.78Cr 2.55Cr 4.8Cr 328.25Cr 4.87Cr 33Cr 13Cr 164.22Cr 13Cr 13Cr 546.93Cr
Net income - -
Net Debt -5.94TCr -4.19Cr -3.63Cr -3.39Cr -3.1Cr -5.84Cr -399.55Cr -5.93Cr -40Cr -16Cr -199.89Cr -16Cr -15Cr -665.73Cr -6.88TCr -4.85Cr -4.2Cr -3.93Cr -3.59Cr -6.76Cr -462.78Cr -6.87Cr -46Cr -18Cr -231.52Cr -18Cr -18Cr -771.08Cr
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
10/26/10 5,470.00 +4.59% 1,30,329
07/26/07 ₩5,230.00 -0.19% 29,666
06/26/06 ₩5,240.00 +0.19% 37,983
05/26/05 ₩5,230.00 +2.55% 1,35,985
04/26/04 ₩5,100.00 +4.83% 1,33,142

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock